DD156813A5 - Verfahren zur herstellung von estern von 9-hydroxyalkylpurinen - Google Patents
Verfahren zur herstellung von estern von 9-hydroxyalkylpurinen Download PDFInfo
- Publication number
- DD156813A5 DD156813A5 DD81228249A DD22824981A DD156813A5 DD 156813 A5 DD156813 A5 DD 156813A5 DD 81228249 A DD81228249 A DD 81228249A DD 22824981 A DD22824981 A DD 22824981A DD 156813 A5 DD156813 A5 DD 156813A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- acid
- npt
- esters
- cells
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/130,334 US4340726A (en) | 1980-03-14 | 1980-03-14 | Esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD156813A5 true DD156813A5 (de) | 1982-09-22 |
Family
ID=22444200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD81228249A DD156813A5 (de) | 1980-03-14 | 1981-03-12 | Verfahren zur herstellung von estern von 9-hydroxyalkylpurinen |
Country Status (26)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4423050A (en) * | 1981-05-21 | 1983-12-27 | Syntex (U.S.A.) Inc. | 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent |
| JPS58135878A (ja) * | 1981-09-22 | 1983-08-12 | Suntory Ltd | 新規アイラントン誘導体及びその製造法 |
| AU564576B2 (en) * | 1981-09-24 | 1987-08-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Purine derivatives |
| US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
| US4609662A (en) * | 1982-10-14 | 1986-09-02 | Burroughs Wellcome Co. | Method for using purine derivatives |
| HUT36464A (en) * | 1983-05-24 | 1985-09-30 | Newport Pharmaceuticals | Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide |
| JP3005959B2 (ja) * | 1989-03-31 | 2000-02-07 | ヤンマー農機株式会社 | 乗用田植機における植付部伝動構造 |
| US5614504A (en) * | 1990-08-01 | 1997-03-25 | The University Of South Florida | Method of making inosine monophosphate derivatives and immunopotentiating uses thereof |
| US6420374B1 (en) | 1990-11-30 | 2002-07-16 | Fred Hutchinson Cancer Research Center | Use of xanthines as immunosuppressants and to inhibit allograft reactions |
| US6338963B1 (en) | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| BE1008977A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
| AU3786299A (en) | 1998-05-04 | 1999-11-23 | Neotherapeutics, Inc. | Novel serotonin-like 9-substituted hypoxanthine and methods of use |
| US6297226B1 (en) | 1999-10-15 | 2001-10-02 | Neotherapeutics, Inc. | Synthesis and methods of use of 9-substituted guanine derivatives |
| US6288069B1 (en) | 1999-11-16 | 2001-09-11 | Neotherapeutics, Inc. | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| US6407237B1 (en) | 2001-02-21 | 2002-06-18 | Neotherapeutics, Inc. | Crystal forms of 9-substituted hypoxanthine derivatives |
| US6849735B1 (en) | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
| AU2001273212A1 (en) | 2000-07-07 | 2002-01-21 | Neotherapeutics, Inc. | Methods for treatment of drug-induced peripheral neuropathy and related conditions |
| US6759427B2 (en) | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
| KR20060120069A (ko) * | 2003-10-03 | 2006-11-24 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 피라졸로피리딘 및 그의 유사체 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2940966A (en) * | 1958-05-15 | 1960-06-14 | Daniel R Bullard | Glucoside of 2-amino-4-hydroxy-6-(1', 2'-dihydroxypropyl)-pteridine |
| US3862189A (en) * | 1973-08-14 | 1975-01-21 | Warner Lambert Co | Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents |
| US4138562A (en) * | 1977-02-09 | 1979-02-06 | The Regents Of The University Of Minnesota | Adenosine deaminase resistant antiviral purine nucleosides and method of preparation |
| DE2714883A1 (de) * | 1977-04-02 | 1978-10-12 | Basf Ag | Nicht-glykosidische theophyllin- zucker-derivate |
| JPS55113786A (en) * | 1979-02-23 | 1980-09-02 | Toyo Jozo Co Ltd | Novel substance, nepranosin b or f and its preparation |
| US4221909A (en) * | 1978-09-15 | 1980-09-09 | Sloan-Kettering Institute For Cancer Research | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines |
| US4221910A (en) * | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
| US4221794A (en) * | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
-
1980
- 1980-03-14 US US06/130,334 patent/US4340726A/en not_active Expired - Lifetime
-
1981
- 1981-02-12 EP EP81100970A patent/EP0036077B1/en not_active Expired
- 1981-02-12 AT AT81100970T patent/ATE8995T1/de active
- 1981-02-12 DE DE8181100970T patent/DE3165476D1/de not_active Expired
- 1981-02-18 NZ NZ196295A patent/NZ196295A/xx unknown
- 1981-02-19 IN IN94/DEL/81A patent/IN155441B/en unknown
- 1981-02-23 ZA ZA00811181A patent/ZA811181B/xx unknown
- 1981-03-03 AU AU68025/81A patent/AU535052B2/en not_active Ceased
- 1981-03-03 IL IL62258A patent/IL62258A/xx unknown
- 1981-03-03 NO NO810723A patent/NO155579C/no unknown
- 1981-03-11 CA CA000372764A patent/CA1159827A/en not_active Expired
- 1981-03-12 DD DD81228249A patent/DD156813A5/de unknown
- 1981-03-12 PH PH25348A patent/PH19148A/en unknown
- 1981-03-12 GR GR64378A patent/GR74807B/el unknown
- 1981-03-12 PL PL1981230115A patent/PL129094B1/pl unknown
- 1981-03-13 ES ES500321A patent/ES500321A0/es active Granted
- 1981-03-13 DK DK115081A patent/DK154768C/da not_active IP Right Cessation
- 1981-03-13 HU HU81645A patent/HU187324B/hu not_active IP Right Cessation
- 1981-03-13 FI FI810774A patent/FI67848C/fi not_active IP Right Cessation
- 1981-03-13 RO RO81103677A patent/RO82509A/ro unknown
- 1981-03-13 IE IE552/81A patent/IE51019B1/en not_active IP Right Cessation
- 1981-03-13 YU YU651/81A patent/YU41973B/xx unknown
- 1981-03-13 CS CS811846A patent/CS235514B2/cs unknown
- 1981-03-13 PT PT72665A patent/PT72665B/pt not_active IP Right Cessation
- 1981-03-13 JP JP3546781A patent/JPS572287A/ja active Granted
- 1981-03-13 KR KR1019810000822A patent/KR850000320B1/ko not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD156813A5 (de) | Verfahren zur herstellung von estern von 9-hydroxyalkylpurinen | |
| DE3227262C3 (de) | Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor | |
| JPS6110589A (ja) | 新規化合物、その製法およびその用途 | |
| DE3001585A1 (de) | Verfahren zur herstellung von interferon typ ii und es enthaltende zubereitungen | |
| EP0003833A2 (de) | Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate | |
| DE68922109T2 (de) | Gamma-inulin-zusammensetzungen. | |
| DE3448149C2 (cg-RX-API-DMAC7.html) | ||
| DE69704057T2 (de) | Terphenylverbindungen und sie enthaltende arzneimittel | |
| EP0137193A2 (de) | Chromonalkaloid, Verfahren zu seiner Isolierung aus Dysoxylum Binectariferum, und seine Verwendung als Arzneimittel | |
| DE69634530T2 (de) | Antivirales mittel und verfahren zu dessen herstellung | |
| DE69530857T2 (de) | Therapeutische quassinoid-zubereitungen mit antineoplastischer, antiviraler und herbistatischer wirkung | |
| DE3786304T2 (de) | Immunostimulierende Arzneimittel. | |
| DE2522090A1 (de) | Pyrimidinol-verbindungen und verfahren zu ihrer herstellung | |
| DE1965431B2 (de) | Inosin-Komplexverbindungen und Verfahren zu ihrer Herstellung | |
| US4457919A (en) | Method of imparting immunomodulating, antiviral or antitumor activity | |
| DE2048848A1 (de) | Verfahren zur Herstellung eines Korn plexes aus RNS und Polysacchand, Verfahren zur Gewinnung der Polysacchand Komponente und ihre Verwendung zur Herstellung von Arzneimitteln | |
| DE2911353A1 (de) | 3-o-( beta -d-glucoronpyranosyl)- sojasapogenol b, verfahren zu deren herstellung und arzneimittel, welche diese enthalten | |
| DE2818221A1 (de) | 5-jod-5'-amino-2',5'-dideoxycytidin und seine verwendung | |
| DE3634496C2 (de) | Glukosylmoranolinderivate und ihre Herstellung | |
| DE3782169T2 (de) | Verfahren zur herstellung von antibiotica 10381b. | |
| DE2851629A1 (de) | Biologisches peptolidpraeparat, verfahren zu seiner herstellung und dieses praeparat enthaltende arzneimittel | |
| DE60112482T2 (de) | Verbindungen mit antioxidierender Wirkung, diese enthaltende Zusammensetzungen zur Nahrungsmittelergänzung sowie Verfahren zu deren Herstellung | |
| DE2522047A1 (de) | Pharmazeutisches mittel zum induzieren von interferon | |
| DE2803681C2 (cg-RX-API-DMAC7.html) | ||
| EP0173950A2 (de) | Neuer alpha-Glukosidase Inhibitor, Verfahren zur seiner Herstellung, seine Verwendung und pharmazeutische Präparate |